CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients
Conditions: Acute Myeloid Leukemia; Myeloid Neoplasm Interventions: Drug: Liposome-encapsulated Daunorubicin-Cytarabine; Drug: Cladribine; Drug: Cytarabine; Biological: Granulocyte Colony-Stimulating Factor; Drug: Mitoxantrone; Other: Questionnaire Administration; Other: Quality-of-Life Assessment Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI); Jazz Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials